Obtention and Engineering of Non-Human Primate (NHP) Antibodies for Therapeutics

被引:18
作者
Pelat, Thibaut [1 ]
Hust, Michael [2 ]
Thullier, Philippe [1 ]
机构
[1] Ctr Rech, Serv Sante Armees, Grp Biotechnol Anticorps, Dept Biol Agents Transmissibles, F-38702 La Tronche, France
[2] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem & Biotechnol, Braunschweig, Germany
关键词
Antibody; non human primate; immune library; humanization; PHAGE DISPLAY; ANTHRAX TOXIN; HIGH-AFFINITY; RECOMBINANT ANTIBODIES; GERMLINE HUMANIZATION; BACILLUS-ANTHRACIS; NEUTRALIZES; SELECTION; FAB;
D O I
10.2174/138955709791012283
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Recombinant antibodies are therapeutic molecules of choice regarding their efficacy, pharmacokinetics and tolerance - all the more if they are human. The efficacy of antibodies generally depends on their affinity for their antigens. The most straightforward approach to isolate human antibodies with high affinities is the construction and screening of human immune libraries, but Humans cannot be immunized with all antigens of interest, for ethical and practical reasons. We circumvented that difficulty by utilizing non-human primates (NHP) instead of Humans and, in the course of our different studies, we have obtained several antibody fragments with high or very high affinities ( from 3 nM to 50 pM) and neutralizing properties. The framework regions (FR) - the regions most implicated in tolerance - of these NHP antibody fragments were shown to be very similar to FR encoded by human germline genes. In one case, in a process called "germ-line humanization" (or "super-humanization"), we have increased that level of similarity and managed to go even beyond the level observed for human antibodies, without any loss of affinity. Here, the methodological peculiarities of our approach, in comparison with immune libraries built from immunised Humans, and the rationales behind these peculiarities, will be reviewed. The isolation of NHP antibody fragments from immune libraries, followed by the "super-humanization" process, opens a new and highly efficient approach for the production of high-quality recombinant antibodies for therapeutic uses.
引用
收藏
页码:1633 / 1638
页数:6
相关论文
共 24 条
  • [21] Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection
    Stittelaar, KJ
    Neyts, J
    Naesens, L
    van Amerongen, G
    van Lavieren, RF
    Holy, A
    De Clercq, E
    Niesters, HGM
    Fries, E
    Maas, C
    Mulder, PGH
    van der Zeijst, BAM
    Osterhaus, ADME
    [J]. NATURE, 2006, 439 (7077) : 745 - 748
  • [22] Superhumanized antibodies: Reduction of immunogenic potential by complementarity-determining region grafting with human germline sequences: Application to an anti-CD28
    Tan, P
    Mitchell, DA
    Buss, TN
    Holmes, MA
    Anasetti, C
    Foote, J
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (02) : 1119 - 1125
  • [23] Phage Display Derived Therapeutic Antibodies
    Thie, Holger
    Meyer, Torsten
    Schirrmann, Thomas
    Hust, Michael
    Duebel, Stefan
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2008, 9 (06) : 439 - 446
  • [24] Human antibodies from immunized donors are protective against anthrax toxin in vivo
    Wild, MA
    Xin, H
    Maruyama, T
    Nolan, MJ
    Calveley, PM
    Malone, JD
    Wallace, MR
    Bowdish, KS
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (11) : 1305 - 1306